HOME >> BIOLOGY >> NEWS
Influenza infection attracts pneumonia bacteria

SALT LAKE CITY May 22, 2002 -- Lung cells infected with the influenza A virus are more likely to bind with bacteria that cause pneumonia than uninfected cells, but this phenomenon can be reversed with antiviral treatment. Researchers from the University of Kansas Medical Center present their findings today at the 102nd General Meeting of the American Society for Microbiology. Bacterial pneumonia caused by Streptococcus pneumoniae can occur secondary to viral infections such as influenza. Previous studies have shown that by treating the influenza virus with Tamiflu, a neuraminidase inhibitor that attacks the influenza virus at the cellular level, secondary complications such as pneumonia can be reduced, says Dr. Rebecca Horvat, one of the researchers on the study.

Dr. Horvat and her colleagues examined the relationship between the binding of S. pneumoniae bacteria to a lung epithelial cell line (the cells that line the respiratory system) with and without influenza A infection. Preliminary studies showed that after 24, 48 or 72 hours of viral infection, the bacteria bound to the influenza-infected cells 4 to 10 times higher than uninfected cells. When the flu virus was treated with Tamiflu, the increased binding was reversed.

An influenza-infected lung epithelial cell will bind more S. pneumoniae bacteria than uninfected cells. Treatment with Tamiflu at doses used to treat influenza infections can prevent this increased bacterial binding, and perhaps prevent post-influenza complications, such as pneumonia, says Dr. Horvat.

S. pneumoniae continues to be the leading cause of community-acquired pneumonia worldwide. Although the ability of bacteria to bind to host cells is the first step in the process of infection, few studies have correlated S. pneumoniae cell binding with the severity of lower respiratory tract infections. Dr. Horvat notes that this study has implications only for influenza A infections and additional research must be done on in
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
22-May-2002


Page: 1 2

Related biology news :

1. Experts Say That Future Inhaled Anti-Viral Drug, Zanamivir Is Effective For Treatment And Prevention Of Influenza
2. Anti-Microbial Agent Kills Influenza Virus
3. Scientists Discover How Influenza Virus Becomes More Deadly
4. Virologists Track New Influenza Threat
5. USC study links historical increases in life span to lower childhood exposure to infection
6. Byproduct of water-disinfection process found to be highly toxic
7. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Promising hospital anti-infection strategy probably wont work, study shows
10. Viral proteins may prevent bacterial infections
11. Researchers develop better understanding of immune response to viral infection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/3/2018)... ... November 01, 2018 , ... The Conference ... be held February 6-8, 2019 at the Crowne Plaza Times Square in New ... plenary session is Genentech’s Global Franchise Leader in Cancer Immunotherapy Biomarkers and IO360° ...
(Date:11/3/2018)... Colo. (PRWEB) , ... November 01, 2018 , ... As ... Union (EU) continue to alter the landscape of quality systems for manufacturers worldwide. To ... medical device makers must act on now. , “While 2020 may sound far off, ...
(Date:10/31/2018)... Fla. (PRWEB) , ... October 31, 2018 , ... ... mark of its FebriDx® test, clearing the way for its immediate launch in ... rapid, accurate, and simple to use point-of-care test that is expected to contribute ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... YORK (PRWEB) , ... November 05, 2018 , ... ... is launching live educational support for healthcare professionals through its website, http://www.glycomark.com ... will offer a live chat and video option via the website in November ...
(Date:11/3/2018)... ... November 01, 2018 , ... ... Consortium Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, ... safety and ensure data reliability. , What should clinical research industry stakeholders keep ...
(Date:10/31/2018)... , ... October 30, 2018 , ... Rooam , ... launch operations in Chicago this winter. After its acquisition of the Tally payment app, ... transactions and set default tips, Rooam will grow its market share and increase the ...
(Date:10/31/2018)... Calif. (PRWEB) , ... October 30, 2018 , ... Pippa Rose is a young Labrador ... around one year old, Pippa suffered a partial tear to the cruciate ligament in her ... to run or go on walks. Kinsley reported that it broke her heart to ...
Breaking Biology Technology:
Cached News: